Randomized Controlled Single-blind Trial to Evaluate the Mobile Tracking of Symptoms in Ambulatory Breast Cancer Patients

You may be eligible if

• female
• 18 years old and older
• German speaking
• written informed consent
• beginning of intravenous chemotherapy in the breast care center
• diagnosis breast cancer
• personal smartphone (own device)